Clinical drug development is a complex process...
and Randomization and Trial Supply Management (RTSM) or Interactive Response Technology (IRT) solutions are critical components of this process.
Clinical drug development is a complex process, and Randomization and Trial Supply Management (RTSM) or Interactive Response Technology (IRT) solutions are critical components of this process.
Yet, as clinical trials become more complex in terms of data and size, RTSM and IRT solutions can often fall short, frustrating clinical trials professionals, delaying studies, and slowing time to market. In a recent study commissioned by Oracle Health Sciences and conducted by Informa Pharma Intelligence, 254 clinical operations, trial management, and related functional professionals responded about the needs of study teams related to existing RTSM/IRT solutions.
Survey results include:
- The most common frustrations associated with existing RTSM/IRT systems
- The effect of RTSM/IRT integration into eClinical platforms
- Opportunities for improving current RTSM/IRT systems

Complete the form below to receive your White Paper: